Stokes M (2006) CST Curation Set: 2079; Year: 2006; Biosample/Treatment: cell line, M059K/UV; Disease: glioblastoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]Q Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Ser/Thr) ATM/ATR Substrate Antibody Cat#: 2851

This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.

Click on the protein name to open the protein page, and on the RSD number to open the site page.

Download

S108-p - MCM2 (human) ▲
Modsite: DVEELtAsQREAAER SwissProt Entrez-Gene Orthologous residues MCM2 (human): S108‑p, MCM2 (mouse): S108‑p, MCM2 (rat): S109‑p, MCM2 (cow): S109‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Relevant cell lines - cell types - tissues:  M059K (glial)

S365-p - NEXN (human) ▲
Modsite: PEMyKtIsQEFLtPG SwissProt Entrez-Gene Orthologous residues NEXN (human): S365‑p, NEXN iso4 (human): ‑, NEXN (mouse): S296‑p, NEXN (rat): S345‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Relevant cell lines - cell types - tissues:  M059K (glial)

S823-p - TIF1B (human) ▲
Modsite: sLPGAGLssQELsGG SwissProt Entrez-Gene Orthologous residues TIF1B (human): S823‑p, TIF1B iso2 (human): S741‑p, TIF1B (mouse): S823‑p, TIF1B (rat): S824‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Relevant cell lines - cell types - tissues:  M059K (glial)

S824-p - TIF1B (human) ▲
Modsite: LPGAGLssQELsGGP SwissProt Entrez-Gene Orthologous residues TIF1B (human): S824‑p, TIF1B iso2 (human): S742‑p, TIF1B (mouse): S824‑p, TIF1B (rat): S825‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Relevant cell lines - cell types - tissues:  M059K (glial)